Почетна › Рак дојке › Kalifornija › Santa Monica
Kliničke studije za Рак дојке u gradu Santa Monica, CA
29 studija za Рак дојке traži učesnike na lokacijama u gradu Santa Monica i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Тражи се учесникФаза 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Тражи се учесникФаза 1/2
- Research Facility, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Тражи се учесникФаза 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 ми удаљено
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Тражи се учесник
- UCLA David Geffen School of Medicine, Santa Monica
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Тражи се учесникФаза 3
- Beverly Hills Cancer Center, Beverly Hills · 6 ми удаљено
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Тражи се учесникФаза 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
Тражи се учесникФаза 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 ми удаљено
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Тражи се учесникФаза 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Тражи се учесникФаза 1
- University of California, Los Angeles (UCLA), Santa Monica
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- Tower Cancer Research Foundation, Beverly Hills · 6 ми удаљено
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 ми удаљено
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 ми удаљено
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Тражи се учесникФаза 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Тражи се учесникФаза 2
- University of California Los Angeles, Santa Monica
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
Тражи се учесникФаза 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 ми удаљено
A Study of PHST001 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 ми удаљено
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Тражи се учесникФаза 2
- Beverly Hills Cancer Center, Beverly Hills · 6 ми удаљено
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Тражи се учесникФаза 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Kivu Trial Site, Santa Monica
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Тражи се учесникФаза 3
- Clinical Trial Site, Beverly Hills · 6 ми удаљено
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- и још 1
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Тражи се учесникФаза 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 ми удаљено
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Тражи се учесникФаза 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 ми удаљено
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Тражи се учесникФаза 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Тражи се учесникФаза 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 ми удаљено
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 ми удаљено
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Тражи се учесникФаза 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Тражи се учесникФаза 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 ми удаљено
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Тражи се учесникОпсервациона студија
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Santa Monica
- Немалоклетни карцином плућа45 студија
- Рак (све врсте)21 студија
- Колоректални карцином20 студија
- Метастатски карцином17 студија
- Рак простате15 студија
- Рак јајника14 студија
- Рак плућа14 студија
- Плоскоклеточни карцином главе и врата12 студија
- Затајење срца10 студија
- Рак панкреаса9 студија
- Рак јетре (хепатоцелуларни карцином)9 студија
- Карцином ендометријума9 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.